Barclays analyst Lauren Lieberman lowered the firm’s price target on Church & Dwight to $84 from $94 and keeps an Underweight rating on the shares. The company’s guidance assumes an inflection back to category growth in the second half of 2025 while also contemplating a consumer that remains under pressure, the analyst tells investors in a research note. The firm, however, does not yet see a catalyst for category growth to improve, particularly given Church & Dwight’s dependence on premium and more discretionary brands like Hero and Therabreath.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CHD:
- Church & Dwight price target lowered to $100 from $105 at RBC Capital
- Positive Outlook on Church & Dwight Despite Short-term Challenges, Strategic Initiatives and Strong Financial Position Justify Buy Rating
- Church & Dwight Reports Q1 2025 Earnings and Strategic Updates
- Church & Dwight’s Earnings Call: Mixed Sentiments and Strategic Focus
- Buy Rating Affirmed Despite Mixed Earnings Quality: Church & Dwight’s Strategic Positioning and Operational Efficiency Highlighted
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue